ISSN-registered · Peer-reviewed · Open Access
JournalsAboutContact
Submit Manuscript
Research Topic

NSCLC

2 article(s) on this topic across our journals.

Erlotinib plus bevacizumab vs erlotinib monotherapy as first line treatment
The Clinical Lung Cancer

Developments and Difficulties of Messenger RNA Vaccines in NSCLC Therapy
Advances in Vaccines